Certificate of Pharmaceutical Products (COPP) Apostille for Saudi Arabia

An apostille for a Certificate of Pharmaceutical Products (COPP) is required to ensure that U.S.-issued documents verifying the manufacturing, quality, and regulatory status of pharmaceutical products are officially recognized for use in the Saudi Arabia.

This process confirms the authenticity of signatures, seals, and issuing federal authorities, allowing the COPP to be accepted by Saudi regulatory bodies, importers, and distributors for registration, importation, and compliance purposes.

Eligible Document Description

A Certificate of Pharmaceutical Products (COPP) is an official document issued by a U.S. federal or authorized agency confirming that a pharmaceutical product complies with applicable regulatory standards and is approved for export.

It typically includes:

  • Product name and dosage form

  • Manufacturer and production site

  • Registration or approval status

  • Compliance with U.S. pharmaceutical regulations

  • Authorized signatures and official seals

Federal Documents Processing Time & Fees.

Service Fees Processing Time
Service fee $62 -
U.S. Department of State fee $20 9
U.S. Arab chamber of commerce stamp $35 1
Total $117 10 business days

Apostille Process

Federally issued COPPs are authenticated by the U.S. Department of State in Washington, D.C. Once completed, an apostille is attached, making the document legally recognized for official use in the Saudi Arabia.

This apostille replaces embassy legalization and ensures international acceptance under the Hague Apostille Convention.

Important Notes

  • Documents without proper federal authentication cannot be apostilled.

  • Altered, incomplete, or improperly certified COPPs will be rejected.

  • An apostille confirms only the authenticity of signatures and seals, not the quality, safety, or regulatory compliance of the pharmaceutical product.

  • Applicants should confirm all pharmaceutical import and regulatory requirements with the relevant authorities in Saudi Arabia before submission.